Tongue suspension device and method

• US 8,973,582 B2
• Filed: 11/30/2011
• Issued: 03/10/2015
• Est. Priority Date: 11/30/2011
• Status: Active Grant

• Current Assignee: Ethicon Incorporated (Johnson & Johnson)
• Original Assignee: Ethicon Incorporated (Johnson & Johnson)
• Inventors: Rousseau, Robert A.
• Primary Examiner(s): Nia, Alireza
• Assistant Examiner(s): HAWTHORNE, OPHELIA ALTHEA
• Application Number:
  US13/307,482
• Publication Number:
  US 20130133669A1
• Time in Patent Office: 1,196 Days
• Field of Search: 128/848, 128859-862, 128/207.18, 623/9, 623/23.72, 433 6- 7, 600 29- 30, 600/216, 600/228, 606/231, 606230-233, 606/228
• US Class Current: 128/848
• CPC Class Codes: A61F 5/566 Intra-oral devices

Abstract

An implantable tissue suspension device and its method for use. The device includes first and second filamentary elements bonded together only at a central connection region such that first and second leading and trailing legs of the respective first and second filamentary elements extend outwardly from the central connection region. The method includes implanting the device such that the central connection region extends laterally across a patient'"'"'s tongue and the first and second leading and trailing legs of the first and second filamentary elements extend through the tongue such that ends thereof are positioned external to the genioglossus muscle.

Claims

1. A method for treating obstructive sleep apnea comprising:

obtaining an implantable tissue suspension device having first and second filamentary elements each having first and second free ends and a length extending therebetween, said first and second filamentary elements being bonded directly together only at a single discrete connection region centrally located between their respective first and second ends such that a first leading leg of the first filamentary element extends outwardly from a first end of the connection region to the first free end of the first filamentary element, a first trailing leg of the first filamentary element extends outwardly from a second opposite end of the connection region to the second free end of the first filamentary element, a second leading leg of the second filamentary element extends outwardly from the first end of the connection region to the first free end of the second filamentary element, and a second trailing leg of the second filamentary element extends outwardly from the second end of the connection region to the second free end of the second filamentary element;

implanting the connection region of the tissue suspension device laterally across a patient'"'"'s tongue; and

passing the first and second leading and trailing legs of the first and second filamentary elements through the tongue such that the respective free ends of the filamentary elements are positioned external to a genioglossus muscle.

2. The device according to claim 1, wherein the first and second filamentary elements are comprised of a biocompatible, polymeric material.

3. The device according to claim 2, wherein the first and second filamentary elements are comprised of an absorbable material.

4. The device according to claim 3, wherein the first and second filamentary elements are comprised of polydioxanone or polyglactin.

5. The device according to claim 2, wherein the first and second filamentary elements are comprised of a material selected from the group consisting of polypropylene, Poly(hexafluoropropylene-VDF), and nylon.

6. The device according to claim 2, wherein the first and second filamentary elements are comprised of a combination of absorbable and non-absorbable materials.